The research, led by Adam Biran of Newcastle University together with colleagues from NHS trusts and academic institutions across the United Kingdom, set out to explore how survivors of pelvic cancers access and receive information about chronic bowel symptoms after radiotherapy, and to build a framework that could guide improvements in how such information is provided. The team conducted semi-structured interviews with 28 cancer survivors, 14 treated for prostate cancer, 10 for gynecological cancers and 4 for anal or rectal cancers, all of whom had experienced chronic bowel symptoms following pelvic radiotherapy. They also interviewed 19 health professionals involved in the care of these patients. Participants were recruited through UK cancer charities and five NHS hospital trusts, and interviews took place remotely between November 2021 and September 2022, lasting up to 90 minutes for survivors and 60 minutes for clinicians.

The interviews were recorded, transcribed and analyzed thematically using NVivo software, with the researchers adopting a subtle realist approach that treats participants’ accounts as meaningful reflections of their experiences while acknowledging the influence of context and perspective. From this analysis, the researchers organized the data into three temporal categories reflecting the cancer journey, pre-treatment, recognizing symptoms, and managing symptoms, plus two cross-cutting themes covering information sources and the challenges of information provision. This structure then informed a provisional framework for information provision, which was reviewed and refined by five public and patient representatives with personal experience of bowel symptoms after cancer.

One of the most striking findings concerns the period before treatment. Health professionals reported that they routinely warn patients about possible short- and long-term effects of radiotherapy as part of the consent process, and some survivors recalled receiving printed material to this effect. Yet not everyone remembered being told about possible late effects, and even those who received the information often could not absorb it. As one 48-year-old woman put it, her priority at the time was simply survival: she wanted not to die, and details about potential long-term problems went to the back of her mind. Another survivor noted that the hospital gave information at the start but never highlighted that there could be an ongoing problem caused by the radiotherapy. Many patients also perceived no meaningful choice about the treatment itself, with one explaining that she could not make an informed decision because there was no decision to make, she had to have the radiotherapy.

The consequences of this information gap became apparent when symptoms emerged, sometimes months or years after treatment. Because late effects are unexpected, delayed in onset and often multiple and disparate in nature, survivors frequently failed to attribute them to their radiotherapy, misattributing them to other causes instead. Some described being alarmed by symptoms such as incontinence or anal bleeding, with clinicians noting that bleeding in particular could be frightening for the unprepared. Others described a sudden moment of realization upon stumbling across relevant information. One 65-year-old woman recounted scrolling a news feed when the Pelvic Radiation Disease Association popped up; having never heard of pelvic radiation damage, she read on and described it as a light bulb moment, realizing that the description matched her own experience exactly. Such chance discoveries, the researchers argue, highlight how fragile the current pathway to understanding is.

Once symptoms were recognized, survivors sought information to help manage them, most commonly around diet, since many suspected that what they ate and drank influenced their symptoms. But this information proved hard to find. In the absence of guidance, some survivors experimented on their own, potentially imposing unnecessary dietary restrictions, while others wondered whether further changes might help. One woman described being passed to a hospital dietitian who, upon hearing her history, said there was nothing she could do for her, leaving the patient to devise her own dietary approach. Health professionals themselves acknowledged the importance of dietary advice, both to prevent over-restriction and to help patients find appropriate alternatives, but the study suggests that access to such support is inconsistent at best.

The study also mapped where survivors turned for information. Beyond health professionals, participants commonly cited cancer charities and the NHS website, with academic literature, support groups and word-of-mouth mentioned less often. The internet was the dominant gateway, and participants were well aware of the risk of misinformation, naming the NHS, Macmillan and Jo’s Trust as trusted sources with up-to-date, reliable material. Support groups offered valuable peer learning and a point of comparison, but not everyone wanted to join them, and one participant noted that groups could themselves spread misinformation. The researchers caution that hearing other survivors’ personal experiences carries further risks: learning that others have more severe symptoms may deepen a sense of gratitude that inhibits care-seeking, and salient anecdotes may carry undue weight in treatment decisions compared with rigorous evidence, a concern that is particularly pertinent amid the rapid growth of medical misinformation online.

Underlying all of these accounts was a structural dilemma about timing. Information given before treatment may never be absorbed, because patients’ attention is consumed by the diagnosis itself. Information given at the end of treatment may not be retained until symptoms appear, which for some survivors is years or even decades later. One clinician highlighted the problem of so-called legacy patients, treated long ago and now difficult to reach, and suggested that checking and repeating information over time may be needed rather than one-off provision. Survivors themselves proposed that the end of radiotherapy might be a better moment to explain the possibility of long-term effects and what to look out for. Gaps in content were also identified, including information on discussing late effects with employers, tailored material for young adults who have left home but not yet started a family, and better education for health professionals, some of whom appeared slow to absorb improved guidance.

From these findings, the team built a provisional framework that maps the purpose of information, the channels through which it can be delivered, survivors’ needs at different time points, and the challenges and considerations for implementation. It deliberately combines patient-level solutions, such as layering information for better retention, web apps and clinically endorsed videos of lived experience, with systems-level measures, such as clinical checklists, integration with electronic record systems and clearer roles for primary and secondary care. The framework is intended to complement existing survivorship initiatives, including survivorship care plans, electronic symptom self-reporting and nurse-led clinics, and the authors believe its elements could apply more broadly to survivors of other treatments such as endocrine therapy and immunotherapy, with appropriate tailoring.

The authors are candid about the study’s limitations. Nearly all participants identified as White British, recruitment through charities may have skewed the sample toward more engaged individuals more likely to have sought information, and memories of events years past may have been colored by subsequent experiences. Even so, the central message is difficult to ignore: access to timely, relevant and accurate information was a problem across the entire cancer journey for this group, and individual information needs are so disparate that they cannot be fully known at the outset and change over time. As healthcare systems shift away from hospital-based follow-up toward supported self-management, the ability of survivors to recognize delayed symptoms and seek help becomes critical. The researchers’ next step is to refine the framework with survivors, particularly those from marginalized groups not represented in this study, and with practitioners, before co-developing the information resources that could finally close a gap that has left too many survivors, in the words of the study’s earlier work, cast adrift.

Subject of Research: Information access and provision for cancer survivors with chronic bowel symptoms after pelvic radiotherapy

Article Title: A qualitative exploration of information access and provision for cancer survivors experiencing chronic bowel symptoms after pelvic radiotherapy: informing a framework to guide improvements to information provision

Article References: Biran, A., Dobson, C., Maybury, J., Rees, C. J., Brooks-Pearson, R., Cunliffe, A., Durrant, L., Hancock, J., Neilson, L. J., Wilson, A., & Sharp, L. (2026). A qualitative exploration of information access and provision for cancer survivors experiencing chronic bowel symptoms after pelvic radiotherapy: informing a framework to guide improvements to information provision. Supportive Care in Cancer, 34(10), Article 999. https://doi.org/10.1007/s00520-026-11040-y

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11040-y

Keywords: cancer survivors, pelvic radiotherapy, chronic bowel symptoms, pelvic radiation disease, information provision, qualitative research, supportive care, self-management, late effects, health communication, survivorship, NHS

The scale of the problem is striking. Adolescents and young adults, typically defined as patients diagnosed between roughly 15 and 39 years of age, represent a growing survivor population, and so do adults who were treated for cancer as children. Both groups now live for decades after their diagnoses, thanks to dramatic improvements in oncology care. But longevity brings chronic health conditions, ongoing surveillance, and repeated interactions with an expensive health care system. The review positions financial hardship alongside cardiac dysfunction, secondary cancers, and other well-known late effects, arguing that it deserves the same clinical attention because it directly undermines quality of life and deepens health inequities.

The drivers of financial hardship in these populations are distinctive. High out-of-pocket medical costs top the list, and studies cited in the review show that survivors of adolescent and young adult cancers carry additional medical expenditures linked to chronic conditions and psychological distress compared with peers who never had cancer. French cohort studies of long-term pediatric solid tumor survivors documented excess health care expenditures persisting well into adulthood. In the United States, analyses from the Childhood Cancer Survivor Study found that even after the Affordable Care Act expanded insurance coverage, substantial numbers of adult survivors of childhood cancer continued to report material hardship, including difficulty paying bills, skipped payments, and food insecurity.

Employment disruption compounds the damage. Young survivors are at a life stage when careers, savings, and independence are supposed to be built, yet cancer interrupts education and derails workforce entry. The review highlights evidence of job lock, a phenomenon in which survivors remain in unsuitable or lower-paying jobs simply to keep employer-sponsored health insurance. A meta-analysis dating back to 2006 already showed elevated unemployment among adult survivors of childhood cancer, and more recent work from the Childhood Cancer Survivor Study linked chronic health conditions to longitudinal employment losses, with productivity losses among these survivors estimated to impose an annual economic burden in the billions of dollars nationally.

Fertility preservation adds another layer of financial strain that is largely unique to young patients. Gonadotoxic therapies threaten future fertility, and guidelines recommend discussing preservation options before treatment begins. But sperm banking, egg freezing, and embryo cryopreservation are expensive, insurance coverage is inconsistent, and only a patchwork of state laws mandates coverage. Qualitative studies and social media analyses cited in the review show that cost frequently shapes whether young patients pursue preservation at all, turning a deeply personal reproductive decision into a financial one. Female survivors who pursued fertility preservation reported greater subsequent financial hardship, illustrating how a single early decision can echo across years of survivorship.

The burden is not distributed evenly. The review identifies racial and ethnic minorities, LGBTQIA+ individuals, and rural residents as facing disproportionate risk. A cross-sectional study of adolescent and young adult survivors in Kentucky documented racial and rural disparities in financial toxicity and in the transitions between pediatric and adult health care. Research during the COVID-19 pandemic found that LGBTQIA+ young survivors experienced compounded financial burden and worse mental health, while pandemic-related employment disruptions hit young adult survivors particularly hard because many worked in vulnerable sectors. Neighborhood socioeconomic disadvantage also correlates with financial hardship among long-term childhood cancer survivors, suggesting that structural factors beyond the clinic shape who pays the steepest price.

The consequences extend well beyond bank accounts. Financial hardship is linked to treatment non-adherence, delayed follow-up care, and adverse psychosocial outcomes. Survivors worried about money may skip surveillance mammograms, echocardiograms, or endocrine checks precisely when early detection of late effects matters most. Emerging evidence presented at the American Society of Clinical Oncology annual meeting and cited in the review connects financial hardship among childhood cancer survivors to non-adherence with both lifestyle recommendations and surveillance protocols. Psychological dimensions, including anxiety about daily financial needs, depression, and fear of cancer recurrence, intertwine with material hardship, and caregivers and family members absorb part of the distress through their own financial and emotional sacrifices.

Care transitions and insurance changes act as danger points where hardship can spike. Survivors moving from pediatric to adult care often lose coordinated support, and young adults aging off parental insurance plans face coverage cliffs at exactly the moment long-term surveillance needs intensify. Studies of hematopoietic cell transplant survivors, a group with intensive long-term needs, found pronounced age and gender differences in financial distress. Meanwhile, Medicaid expansion has changed enrollment patterns among childhood cancer survivors, and research is ongoing into how such policy shifts affect screening adherence, including cardiomyopathy monitoring among Medicaid-enrolled survivors.

Interventions remain limited but are beginning to take shape. The review highlights early financial risk screening at diagnosis, the integration of financial navigation into oncology and survivorship care, and educational programs that teach survivors about insurance. Pilot studies of oncology financial navigation programs, financial toxicity screening implementations, and health insurance navigation tools tested within the Childhood Cancer Survivor Study suggest that structured support can reduce distress and improve coverage decisions. One-time financial grants have shown early promise for young adult survivors, and digital tools, including social media peer support and online resource delivery, offer scalable ways to reach survivors who live far from specialized centers. European Society for Medical Oncology consensus statements now call for systematic screening and management of financial toxicity, signaling growing international recognition of the problem.

The authors conclude that significant gaps persist. Prospective, population-based research is scarce; most evidence is cross-sectional and skewed toward survivors engaged with academic health systems. Culturally tailored interventions for underserved survivors are largely absent, and systematic inclusion of racial minorities, rural residents, and LGBTQIA+ survivors in intervention trials remains rare. The review’s central message is that solving financial hardship will require coordinated clinical, policy, and community action: clinics must screen and navigate, insurers and lawmakers must decouple coverage from employment and expand fertility preservation benefits, and communities must support survivors who fall through the cracks. Until then, financial toxicity will remain a silent late effect, shaping the lives of young cancer survivors long after their treatment ends.

Subject of Research: Financial hardship and financial toxicity among adolescent and young adult cancer survivors and adult survivors of childhood cancer

Article Title: Financial hardship in adolescent and young adult cancer survivors and adult survivors of childhood cancers

Article References: Garg, A., Monick, S., Kimball, B., Bhatt, N. S., Khera, N., & Rosenthal, A. (2026). Financial hardship in adolescent and young adult cancer survivors and adult survivors of childhood cancers. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02133-y

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02133-y

Keywords: financial toxicity, cancer survivors, adolescent and young adult oncology, childhood cancer survivors, health equity, survivorship care, employment disruption, fertility preservation, health insurance, financial navigation, late effects, health disparities

The research, conducted by Jean C. Yi, Sheri Ballard, Emily Jo Artim, Casey Walsh, and K. Scott Baker at Fred Hutchinson Cancer Center, took a mixed methods approach, combining hard utilization data from the electronic health record with in-depth qualitative interviews. All participants were one to five years past the end of cancer treatment, a window when survivorship care is considered especially critical. The team queried the electronic health record to determine which survivors had been seen in the Survivorship Clinic, then conducted qualitative interviews with a randomly selected subset of participants drawn from a larger parent study testing a digital health intervention. That parent trial, known as INSPIRE—the INteractive survivorship program to improve health care REsources—is designed to test a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors.

The demographic profile of the small group that did use the clinic was telling. Among the 38 clinic users, 86.8 percent were female, 71.1 percent were White, 86.8 percent were not Hispanic, and 65.7 percent had been treated for breast cancer. This skew toward female, White, and breast cancer populations raises questions about equitable reach, though the study’s primary focus was on understanding why utilization was so low across the board. The picture that emerged from the electronic health record was unambiguous: survivorship services, even when available at the very institution where these patients had been treated, were being used by fewer than one survivor in twenty.

To understand the reasons behind those numbers, the researchers screened a subset of 147 participants enrolled in the parent trial for approach to qualitative interviews, ultimately completing forty interviews. The interviewees had a mean age of 38.4 years, with half having had breast cancer; 78 percent were female, 83 percent were White, and 92 percent had attained a college degree or higher education. Despite being well educated and demographically similar to the clinic-using group, only one of the forty interview participants had ever visited the Survivorship Clinic. That single data point may be the most arresting in the study: even among survivors engaged enough to enroll in a survivorship research trial, virtually none had accessed the clinic down the hall.

Through content analysis of the interview transcripts, the researchers identified a set of barriers that fell into distinct but interconnected categories. The most significant was simple lack of awareness: many survivors simply did not know the survivorship clinic existed or what services it offered. This was compounded by avoidance—a psychological reluctance to confront cancer again after treatment had ended—and by lack of time, as young adults juggle careers, education, caregiving responsibilities, and the reestablishment of normal life. For a population at the busiest and most transitional stage of adulthood, an additional medical appointment that they had never heard of and did not fully understand carried little apparent urgency.

The interviews also illuminated what would have made a difference. Participants identified referrals from their oncology care teams, concrete information about the services the clinic provides, and the availability of telehealth as factors that would have facilitated them seeking survivorship care. In other words, the barriers were not primarily about motivation or health literacy alone; they were structural and communicative. Survivors needed a trusted clinician to tell them, at the end of treatment, that a survivorship clinic exists and why it matters. They needed to know what would happen during a visit—what late effects would be screened, what symptoms could be addressed, what psychosocial support was available. And they needed flexible access options compatible with the realities of young adult life, including remote participation.

The study arrives at a moment when survivorship care is being formalized at the national level. The National Standards for Cancer Survivorship Care propose health system policies to develop survivorship programs, and the National Comprehensive Cancer Network’s survivorship guidelines, updated in 2025, call for structured follow-up care including survivorship care plans. Yet this research shows that the existence of a clinic, even within a comprehensive cancer center, does not guarantee uptake. Prior work has documented low attendance among childhood cancer survivors and among Hodgkin lymphoma survivors, and studies of rural childhood cancer survivors have similarly pointed to awareness and access as limiting factors. The new study extends that evidence into the adolescent and young adult population, which is demographically and clinically distinct from both pediatric and older adult populations.

That distinctiveness is part of why the gap matters so much. Adolescents and young adults diagnosed with cancer face decades of life after cure, during which late effects—cardiac dysfunction, secondary malignancies, infertility, endocrine problems, cognitive changes, and psychosocial distress—may emerge and progress. Research has consistently shown that this age group experiences unique biology and unique psychosocial burdens, and that their survival gains have historically lagged behind those of children and older adults. Survivorship clinics are designed to catch these late effects early, coordinate surveillance, and connect survivors with interventions. When fewer than five percent of eligible survivors walk through the clinic door, the potential of that model goes largely unrealized, and preventable morbidity may accumulate silently for years.

The implications drawn by the authors are pointed. Lack of awareness of the survivorship clinic was the most significant barrier, and a referral from their oncology care team would have facilitated them scheduling a visit. This suggests a relatively low-cost, high-impact intervention: embedding an explicit survivorship referral into the standard end-of-treatment workflow, paired with clear patient-facing information about what the clinic offers and telehealth options to reduce logistical friction. The study’s connection to the INSPIRE digital health trial also hints at a broader strategy—meeting young survivors where they already are, on their phones, rather than waiting for them to find a clinic they have never heard of. As health systems implement national survivorship standards, the lesson of this study is that building clinics is only half the task; the other half is making sure the patients who need them know they exist.

For survivors themselves, the message is equally practical: late effects are real, monitoring is worthwhile, and help is available beyond the end of treatment. For oncology teams, the message is that the handoff from active treatment to survivorship care cannot be left to chance. A single sentence from a trusted oncologist—a referral, an explanation, an invitation—may be the difference between a young survivor who falls through the cracks and one who receives the long-term surveillance that modern cancer care promises. With 4.5 percent utilization as the baseline, there is enormous room for improvement, and this study offers a clear, evidence-based map of where to begin.

Subject of Research: Utilization of survivorship clinics by adolescent and young adult cancer survivors

Article Title: A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators

Article References: Yi, J. C., Ballard, S., Artim, E. J., Walsh, C., & Baker, K. S. (2026). A mixed methods study of adolescent and young adult cancer survivors and their utilization of a survivorship clinic: Barriers and facilitators. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-026-02125-y

Image Credits: AI Generated

DOI: 10.1007/s11764-026-02125-y

Keywords: adolescent and young adult oncology, cancer survivorship, survivorship clinic, late effects, mixed methods, qualitative interviews, telehealth, health care utilization, barriers and facilitators, cancer survivorship care standards, Fred Hutchinson Cancer Center, digital health intervention